Verve Therapeutics Inc
Biotechnology
Healthcare
VERV
84.63 M shares
NASDAQ US
traded
15 Apr 2025
listed
no
open
4.91
52 week high
8.63
high
5.81
52 week low
2.97
previous Close
4.12
P/E ratio
market cap
489 M
div yield
0
net incoming
-50.13 M
-0.66 %
net profit margin
-730.27 %
13.00 %
operating incoming
-56.91 M
3.28 %
net change in cash
21.99 M
911.55 %
cash on hand
159 M
12.17 %
cost of revenue
1.75 M
5.22 %
top
top